Autoimmune Life Blog

Find out about new advances in autoimmune disease screening from a team led by Cate Speake, PhD.

Read exciting updates and learn what’s on the horizon for 2025 from BRI President Jane Buckner, MD.

Dr. Smithmyer is a staff scientist at Benaroya Research Institute (BRI) in the Center for Interventional Immunology. She has kindly agreed to speak with us about what the BRIDge Biorepository is and its importance to the work that scientists like her do in the realm of type 1 diabetes.

BRI investigators Eddie James, PhD, and Caroline Stefani, PhD, are teaming up to take a unique approach to type 1 diabetes research.

Learn about exciting new type 1 diabetes research Dr. Griffin is taking on at BRI.

Learn how a team led by Carla Greenbaum, MD, is using “fancy math” to better understand not only if a person will develop T1D, but when.

June 1, 2024, marked the second annual Benaroya Research Institute T1D Family Day.

Did you know that if risk screening results show you are in the early stages of T1D, you may be eligible to participate in a type 1 diabetes prevention study?

Learn about one of the first projects launched with this funding, where Eddie James, PhD, and Caroline Stephanie, PhD, are exploring a new approach to treat type 1 diabetes.

Hear from teenagers Clara and Gibson about their experience participating in research and why it's important to them.